Literature DB >> 13269937

Phenylpropyl-hydroxycoumarin as an anticoagulant.

M TOOHEY.   

Abstract

Entities:  

Keywords:  CORONARY DISEASE/therapy; COUMARIN/derivatives; THROMBOSIS/therapy

Mesh：

Substances：

Year:  1956        PMID： 13269937      PMCID： PMC1978641          DOI： 10.1136/bmj.1.4957.9

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  [Experiences with a new anticoagulant (marcoumar)].

Authors:  S SAILER; E KRESBACH
Journal:  Wien Med Wochenschr       Date:  1955-01-08

2.  [Clinical experiences with a new and very effective dicumarol derivative].

Authors:  H HARTERT; I HARTERT
Journal:  Klin Wochenschr       Date:  1953-09-15

3.  Clinical trial of phenylindanedione as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1953-03-21

4.  [A new highly active anticoagulant with prolonged effect (marcoumar)].

Authors:  F KOLLER; H JAKOB
Journal:  Schweiz Med Wochenschr       Date:  1953-05-16

5.  [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].

Authors:  R JURGENS
Journal:  Schweiz Med Wochenschr       Date:  1953-05-16

6.  [Marcumar, 3-1-phenylpropyl-4-oxy-coumarin, a new superdicumarol].

Authors:  P MATIS
Journal:  Arztl Forsch       Date:  1953-06

7.  Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.

Authors:  R BOURGAIN; M TODD; L HERZIG; I S WRIGHT
Journal:  Circulation       Date:  1954-11       Impact factor: 29.690
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.